Trinity Biotech (TRIB) Long-Term Debt Repayments (2021 - 2024)
Historic Long-Term Debt Repayments for Trinity Biotech (TRIB) over the last 6 years, with Q4 2024 value amounting to -$665000.0.
- Trinity Biotech's Long-Term Debt Repayments fell 1917.56% to -$665000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$2.4 million, marking a year-over-year increase of 79.5%. This contributed to the annual value of -$2.5 million for FY2024, which is 798.1% down from last year.
- As of Q4 2024, Trinity Biotech's Long-Term Debt Repayments stood at -$665000.0, which was down 1917.56% from -$558000.0 recorded in Q4 2023.
- Trinity Biotech's 5-year Long-Term Debt Repayments high stood at -$729.0 for Q2 2022, and its period low was -$741000.0 during Q4 2021.
- Moreover, its 4-year median value for Long-Term Debt Repayments was -$574000.0 (2022), whereas its average is -$474684.0.
- In the last 5 years, Trinity Biotech's Long-Term Debt Repayments skyrocketed by 2213.23% in 2022 and then plummeted by 1917.56% in 2024.
- Quarter analysis of 4 years shows Trinity Biotech's Long-Term Debt Repayments stood at -$741000.0 in 2021, then increased by 22.13% to -$577000.0 in 2022, then increased by 3.29% to -$558000.0 in 2023, then fell by 19.18% to -$665000.0 in 2024.
- Its Long-Term Debt Repayments was -$665000.0 in Q4 2024, compared to -$558000.0 in Q4 2023 and -$571000.0 in Q3 2023.